Allogeneic Stem Cell Transplantation in Patients With Mixed Chimerism Following Double Cord Blood Transplantation: A Case Report
Case Reports in Hematology · 2026-01 · 2026 (1)
DOI: 10.1155/crh/2052096 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Hematology, online erschienen am 12.06.2026. Verfasst von Youngrok Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Biology Training Program, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, USA, georgetown.edu. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Double‐unit cord blood transplantation (dCBT) is an established strategy to enhance progenitor cell dose and accelerate hematopoietic recovery when a matched sibling or unrelated donor is unavailable. While dCBT typically results in the dominance of a single unit, the persistence of donor–donor mixed chimerism is an exceptionally rare clinical phenomenon. This case report describes a unique therapeutic strategy where persistent donor–donor chimerism following dCBT was utilized to redefine the recipient’s HLA profile for a subsequent successful allogeneic transplantation. Case Presentation A 38‐year‐old patient with diffuse large B‐cell lymphoma experienced disease relapse following autologous peripheral blood stem cell transplantation. After achieving a second remission through salvage chemotherapy, the patient underwent dCBT due to the absence of a compatible HLA‐matched donor. Fifteen months posttransplantation, the disease relapsed again; however, further salvage therapy successfully induced a third remission. Notably, HLA analysis revealed persistent donor–donor mixed chimerism with one unit maintaining clear dominance. Because no suitable matches existed for the patient’s native HLA type, the dominant donor’s HLA genotype was utilized as the new target for donor selection. This shift facilitated the identification of a matched allogeneic peripheral blood stem cell transplantation (allo‐PBSCT) donor.
Conclusion
The patient subsequently underwent a second allo‐PBSCT based on the dominant donor’s HLA profile. The procedure resulted in robust engraftment and complete donor chimerism without the occurrence of graft‐versus‐host disease. The patient has remained in relapse‐free survival for over 4 years. This case demonstrates that in the rare event of persistent donor–donor chimerism post‐dCBT, the emergent dominant HLA genotype can serve as a viable and effective target for donor selection, providing a life‐saving alternative for patients who lack native HLA‐matched donors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tumor Biology Training Program, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, USA, georgetown.edu.
- Department of Hematology, College of Medicine, Seoul St. Mary's Hospital, Catholic Hematology Hospital and Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea, medcol.mw.
- Department of Internal Medicine, Division of Hematology, College of Medicine, St. Vincent Hospital, The Catholic University of Korea, Seoul, South Korea, medcol.mw.
ORCID-Profile: Youngrok Park, Seonghan Lee, Jinhang Kim, Jeong-A Kim
Zitieren
APA
Park, Y., Lee, S., Kim, J., & Kim, J. A. (2026). Allogeneic Stem Cell Transplantation in Patients With Mixed Chimerism Following Double Cord Blood Transplantation: A Case Report. Case Reports in Hematology, 2026(1). https://doi.org/10.1155/crh/2052096
Vancouver
Park Y, Lee S, Kim J, Kim JA. Allogeneic Stem Cell Transplantation in Patients With Mixed Chimerism Following Double Cord Blood Transplantation: A Case Report. Case Reports in Hematology. 2026;2026(1). doi:10.1155/crh/2052096
BibTeX
@article{Park2026,
author = {Park, Youngrok and Lee, Seonghan and Kim, Jinhang and Kim, Jeong-A},
title = {Allogeneic Stem Cell Transplantation in Patients With Mixed Chimerism Following Double Cord Blood Transplantation: A Case Report},
journal = {Case Reports in Hematology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crh/2052096}
}
EUVIMED